Follow
AliAkbar Movassaghpour
AliAkbar Movassaghpour
Other namesAliAkbar movasagpoor Akbari, AliAkbar movassaghpoor, AliAkbar movasaghpoor
Professor, Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz
Verified email at tbzmed.ac.ir
Title
Cited by
Cited by
Year
The effect of hypoxia on mesenchymal stem cell biology
M Ejtehadifar, K Shamsasenjan, A Movassaghpour, P Akbarzadehlaleh, ...
Advanced pharmaceutical bulletin 5 (2), 141, 2015
2252015
Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment
Y Yaghoubi, AA Movassaghpour, M Zamani, M Talebi, A Mehdizadeh, ...
Life sciences 233, 116733, 2019
1762019
Human umbilical cord mesenchymal stem cell‐derived extracellular vesicles: A novel therapeutic paradigm
H Abbaszadeh, F Ghorbani, M Derakhshani, A Movassaghpour, ...
Journal of cellular physiology 235 (2), 706-717, 2020
1262020
Implications of mesenchymal stem cells in regenerative medicine
S Kariminekoo, A Movassaghpour, A Rahimzadeh, M Talebi, ...
Artificial cells, nanomedicine, and biotechnology 44 (3), 749-757, 2016
1212016
The potential therapeutic effect of melatonin on human ovarian cancer by inhibition of invasion and migration of cancer stem cells
M Akbarzadeh, AA Movassaghpour, H Ghanbari, M Kheirandish, ...
Scientific reports 7 (1), 17062, 2017
1182017
Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy
P Lotfinegad, A Movassaghpour, J Majidi, B Baradaran
Advanced pharmaceutical bulletin 4 (1), 5, 2014
822014
Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells
Z Davoudi, A Akbarzadeh, M Rahmatiyamchi, AA Movassaghpour, ...
Asian Pacific journal of cancer prevention 15 (10), 4353-4358, 2014
752014
Mesenchymal stem cells: new aspect in cell-based regenerative therapy
M Mohammadian, K Shamsasenjan, PL Nezhad, M Talebi, M Jahedi, ...
Advanced pharmaceutical bulletin 3 (2), 433, 2013
712013
Regenerative potential of Wharton's jelly‐derived mesenchymal stem cells: A new horizon of stem cell therapy
H Abbaszadeh, F Ghorbani, M Derakhshani, AA Movassaghpour, ...
Journal of Cellular Physiology 235 (12), 9230-9240, 2020
612020
Novel therapeutic approaches in utilizing platelet lysate in regenerative medicine: Are we ready for clinical use?
M Zamani, Y Yaghoubi, A Movassaghpour, K Shakouri, A Mehdizadeh, ...
Journal of cellular physiology 234 (10), 17172-17186, 2019
612019
Modulatory role of exopolysaccharides of Kluyveromyces marxianus and Pichia kudriavzevii as probiotic yeasts from dairy products in human colon cancer cells
YR Saadat, AY Khosroushahi, AA Movassaghpour, M Talebi, BP Gargari
Journal of Functional Foods 64, 103675, 2020
592020
The role of CD44 in cancer chemoresistance: A concise review
Z Yaghobi, A Movassaghpour, M Talebi, MA Shadbad, ...
European journal of pharmacology 903, 174147, 2021
562021
Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells
B Delalat, AA Pourfathollah, M Soleimani, H Mozdarani, SR Ghaemi, ...
Hematology 14 (3), 125-132, 2009
552009
Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells
B Delalat, AA Pourfathollah, M Soleimani, H Mozdarani, SR Ghaemi, ...
Hematology 14 (3), 125-132, 2009
552009
Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system
A Rahimzadeh, FS Tabatabaei Mirakabad, A Movassaghpour, ...
Artificial cells, nanomedicine, and biotechnology 44 (2), 559-570, 2016
482016
Endothelial cells' biophysical, biochemical, and chromosomal aberrancies in high‐glucose condition within the diabetic range
A Rezabakhsh, E Nabat, M Yousefi, S Montazersaheb, O Cheraghi, ...
Cell biochemistry and function 35 (2), 83-97, 2017
452017
Down‐regulation of intracellular anti‐apoptotic proteins, particularly c‐FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL
A Hassanzadeh, M Farshdousti Hagh, MR Alivand, AAM Akbari, ...
Journal of cellular physiology 233 (10), 6470-6485, 2018
432018
Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: non randomized, open-label clinical trial
M Ahmadi, M Nouri, Z Babaloo, L Farzadi, A Ghasemzadeh, K Hamdi, ...
Immunology letters 192, 12-19, 2017
412017
The pro-Inflammatory cytokines effects on mobilization, self-renewal and differentiation of hematopoietic stem cells
B Jahandideh, M Derakhshani, H Abbaszadeh, AA Movassaghpour, ...
Human Immunology 81 (5), 206-217, 2020
392020
The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia
R Saraei, M Soleimani, AAM Akbari, MF Hagh, A Hassanzadeh, S Solali
Biomedicine & Pharmacotherapy 107, 1010-1019, 2018
392018
The system can't perform the operation now. Try again later.
Articles 1–20